Stock Picks
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I thought it was actually a great interview. Very articulate and well thought out.
$MMMM Quad M Solutions Interview Bullet Points:
-We have been making multiple improvements to enable faster growth.
-The 3 fundamentals of the company are the technology members control, the premium customer experience in the healthcare space, and a strong referral network which alleviates the need for extensive marketing cost.
-Brought over the GEX team which is a world class team of developers.
-Launched a product called My NuAxess for employers to review benefits.
-Also added several new technology partners, including Quantum Computing,Inc. Which will help to lower risk with underwriting.
-Now have a 24 hour operator that people can call to answer all questions.
-We now have a process in place that is perfect for growth.
-Network of Referrals is in place so people will have the confidence to refer clients.
-“I’m excited to show the shareholders what’s going on because everyday we are always focused on increasing shareholder value.”
-“By putting in these fundamentals of the company and making them as strong as we have…I’m excited for the shareholders to continue to have a increased sense of value.”
-“I believe that the stock is completely undervalued!”
-“I will be speaking on a very regular basis now that we have all these pieces in place”
$MMMM will be at a huge conference on April 29th & 30th! I'd imagine some buyers will come in from this.
https://www.wealthbuilderpublishing.co/adventures-in-wealth-building-summit-2022-accredited-investor-bundle/
Renew Your Enthusiasm as Joey Frontiere CEO of Quad M (MMMM) describes their newly perfected automated onboarding process and the thousands of new lives projected for the year ahead!
Yes, it just depends if they dilute all at once and finish this summer or a few million per week over the next 2 years. But yes, I’d think .30-.45 is a good buy area.
They have about 100-140 million more shares to dilute per the fillings over the weekend.
Unfortunately, the reverse split is now inevitable with more shares continuing to hit. I’m very disappointed with how Joey has handled this company. Basically let it dilute non-stop and don’t communicate is his game plan.
Decent numbers on recent financials. I’m hearing management will be doing a conference call and I’m sure they will show us their plan to grow it to 50k-100k lives this year!
They just paid that off last week
Amazing numbers released by NILE!!! as of December 31, 2021, it had over $490 million in total assets and $228 million in stockholders’ equity.
They paid all that off bud. No more debt or dilution left.
Yes, everything looks great for the future with the debt gone! Can you post a link to the video?
Anyone not buying 100 shares a day in their Roth of NILE is a idiot. No debt baby and massive revenue pouring in!
They paid off the debt yesterday
Remember they are able to pick and choose who they keep. They only want to keep healthy people who don’t cost them too much money. So it’s possible that they got rid of some people with chronic health problems. It will just end up making them much more profitable in the long run.
I’m not that excited about these fins. The ones in about a year will be staggering.
Why would the Market Makers let it run when they have it boxed in. It’s simple. Let it go to .27 and short it back down to .21 and then cover and do it all over again.
$MMMM Holy sh*t. Huge Partnership with a Nasdaq company! Quad M expects to apply these applications to over 100,000 insured lives by the end of 2022! We already have 15k lives. 115k lives x $250 profit per month = $28 million profit per month. UNREAL.
https://www.globenewswire.com/news-release/2022/01/19/2369351/0/en/Quantum-Computing-Inc-Provides-Quantum-Consulting-and-Software-to-Quad-M-Solutions.html
Why would you call a company that did $51 million in revenue and made $18 million in gross profit in the first 3 quarters of 2021 a bust? It seems to be the opposite.
Ouch. Loss from operations -3,296,846. Hopefully they turn it around in the next few quarters
Great news today! They basically will be earning $5 million a month in profit by February and will be growing all year. Life changing stock here.
$16 million cash on hand at end of September per the fillings. 2022 is looking nice baby!
Needs to rest and consolidate here before breaking through .60
Yep. I don’t think we hear anything until the full crop is sold.
Do you have info that says otherwise? I know how many were left and I watched them all exercise last week. As you can see today, the price has stabilized and should move back up to new highs momentarily.
Warrants officially completed. We should see new highs this week now that everything is cleaned up. I was able to add at .50 this morning. Ya baby!
$7 million more cash on hand than last year. That’s what matters.
*RAFA* Company “Rafarma Pharmaceuticals Inc.” Combined Financial statements for the period ended, September 30, 2021
Third Quarter Results
https://www.otcmarkets.com/otcapi/company/financial-report/311676/content
Financial Highlights Q3
$51.3 Million in Sales
$18.2 Million Gross Profits
$7.24 Million Income after Taxes
$0.082c Earnings Per Share
$12.4 Million in Cash
87.7 Million Shares Outstanding [unchanged]
Disclosure Statement Q3
https://www.otcmarkets.com/otcapi/company/financial-report/311675/content
That was the end of it. Thank god
Yes. They will be extremely profitable now that they will hit 20,000 lives by January. So no more dilution is needed.
20,000 x $300 = $6 million profit per month.
Well we know 2020 audits are probably done and 2021 audits will be done in a few months. So yes, why not come out with the 2020 audits and let some hedge funds come in. Make sense to me
Major exchanges are absolutely interested in a company with current revenues of $120 million of which will probably double next year.
They should qualify for both NYSE and Nasdaq once the funds are able to buy. Stay tuned.
Not really that slow. They had to go in person to multiple Rafa owned entities in multiple countries with thousands of different products that had to be auditted and already banged out 2020. And they did that during Covid with small travel windows available. Very impressive.
LJ Soldinger is one of the top international auditors in the world and I’m confident they will get us prepared for uplist as soon.
Great. Stay short then. 2020 audit could drop at any second. Tomorrow? Next week? Tick tick.
LOL. A company with unlimited money can do buybacks to get the share price wherever they need. I mean they just put $100 million into the Uzbekistan Pharna Park and $9.5 million into Russia operations. Getting the price to $4 after audits should be no problem especially when funds will be able to buy when the audits drop.
Pretty good actually. 2020 audit done and 2021 done soon.
Loving the news yesterday…”This enables Rafarma to apply for uplisting on a major market platform” So exciting!
2020 audits done now. 2021 audits to be done soon. Tick, tick…
Wrong. There is no dilution to the company shareholders. Verified by IR today. Keep trying.
Great news today!
-Putting $9.5 million into the company to expand operations and planning on uplist to a major exchange. Ya baby!!!
https://www.globenewswire.com/news-release/2021/11/08/2329488/0/en/Status-Update-to-Shareholders-from-Rafarma-Pharmaceuticals-Inc.html